🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-06-12
Trial ID
NCT04181827
Treatments Being Tested
This study aims to evaluate the safety and efficacy of a traditional cholag...
Status
Unknown
Location
Shanghai 10th People's Hospital
Start Date
2018-10-01
Trial ID
NCT03670173
Treatments Being Tested
Primary Objectives: * VCDI cohort: * To determine the maximum tolerated...
Status
Completed
Location
Investigational Site Number : 250002
Start Date
2015-09-30
Trial ID
NCT02513186
Treatments Being Tested
A Phase 3 study to evaluate the efficacy and safety of birtamimab plus stan...
Status
Terminated
Location
Yale Cancer Center
Start Date
2021-08-30
Trial ID
NCT04973137
Treatments Being Tested
This study will assess whether adding one of the newest multiple myeloma th...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2017-07-01
Trial ID
NCT03004287
The purpose of this study is to evaluate how well (efficacy) cilta-cel work...
Status
Recruiting
Location
University of California San Francisco
Start Date
2025-10-03
Trial ID
NCT07149857
Treatments Being Tested
To explore the effectiveness and safety of bortezomib, cyclophosphamide and...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2019-01-01
Trial ID
NCT03982771
Treatments Being Tested
1. Description of the demographic, clinical, and laboratory characteristics...
Status
Unknown
Location
Multiple Locations
Start Date
2024-07-01
Trial ID
NCT06457464
Treatments Being Tested
QUESTIONS AND OBJECTIVES OF ALL-MB 2015 STUDY 1. Will the new risk group s...
Status
Unknown
Location
prof. R.O.Eolyan Hematology Center
Start Date
2015-11
Trial ID
NCT03390387